Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New 5alpha-reductase inhibitors in the pipeline at Kotobuki

March 8, 2000

Merck returns alpha-adrenergic technology rights to Synaptic

March 7, 2000

C5 inhibitor from Alexion granted fast track status for kidney disease

March 2, 2000

Dosing begins in phase II trial of Alprox-TD for erectile dysfunction

Feb. 28, 2000

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Feb. 25, 2000

Synaptic discovers potent and selective human alpha1D-adrenoceptor antagonists

Feb. 24, 2000

Potent and selective alpha1D-adrenoceptor antagonists presented by Abbott

Feb. 18, 2000

Cortex receives notice of allowance for sexual dysfunction patent

Feb. 16, 2000

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Kissei compounds display excellent beta3-adrenoceptor-stimulating effects

Feb. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...